α6GABAA receptor-selective positive allosteric modulator as a novel therapy for fibromyalgia: A proof-of-concept study in mice modeling chronic widespread musculoskeletal pain

Neurotherapeutics · Published 2026-07-01 · DOI 10.1016/j.neurot.2026.e00956

Free full text

Authors (6)

Myles Sant-Cassia, Cheng-Han Lee, V.V.N. Phani Babu Tiruveedhula, James Cook, Chih-Cheng Chen, Lih-Chu Chiou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sant-Cassia, M., Lee, C., Tiruveedhula, V., et al. (2026). α6GABAA receptor-selective positive allosteric modulator as a novel therapy for fibromyalgia: A proof-of-concept study in mice modeling chronic widespread musculoskeletal pain. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e00956

Related articles

• Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial · Neurotherapeutics · 2026 · Same journal
• PrPC modulates BACE1-dependent amyloid pathology under chronic cerebral hypoperfusion: Implications for vascular cognitive impairment · Neurotherapeutics · 2026 · Same journal
• Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing · Neurotherapeutics · 2026 · Same journal
• Identifying treatment-responsive patient subgroups in a neutral clinical trial of Intensive blood pressure reduction in acute intracerebral hemorrhage: A post hoc explainable machine learning analysis · Neurotherapeutics · 2026 · Same journal
• Electric muscle stimulation attenuates neuroinflammation and improves the outcome of acute ischemic stroke in mice · Neurotherapeutics · 2026 · Same journal
• Bilateral intermittent theta burst stimulation over the primary motor cortex improves motor and affective symptoms via thalamic network reintegration in mid-stage Parkinson's disease · Neurotherapeutics · 2026 · Same journal
• Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population? · Neurotherapeutics · 2026 · Same journal
• Sex-specific considerations in migraine therapy · Neurotherapeutics · 2026 · Same journal
• PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke · Neurotherapeutics · 2026 · Same journal
• Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion · Neurotherapeutics · 2026 · Same journal